Lat­est news on Covid vac­cine OK; No­var­tis' 1 win and 1 flop; Eli Lil­ly and the Alzheimer's puz­zle; End of an era for Al­ny­lam; and more

Wel­come back to End­points Week­ly, your re­view of the week’s top bio­phar­ma head­lines. Want this in your in­box every Sat­ur­day morn­ing? Cur­rent End­points read­ers can vis­it their read­er pro­file to add End­points Week­ly. New to End­points? Sign up here.

End­points News is fir­ing on all cylin­ders. In this edi­tion you will find some big news sto­ries from the week, an in-depth fea­ture, plen­ty of ex­clu­sive re­port­ing and the first sto­ries Beth Bu­lik has writ­ten for our brand new Phar­ma Mar­ket­ing chan­nel. Sign up to re­ceive the first edi­tion of her End­points Mar­ket­ingRx newslet­ter next Tues­day — you won’t want to miss it.

Unlock this article instantly by becoming a free subscriber.

You’ll get access to free articles each month, plus you can customize what newsletters get delivered to your inbox each week, including breaking news.

SIGN UP LOG IN BECOME A PREMIUM SUBSCRIBER